Sign In
Sign Up
Two Blokes
KALV Stock Moves More Than 30% in a Week: What Is Driving This Rally?
click to rate
Posted by
Two Blokes
Jul 10
- Filed in
Stock
- 4 views
KalVista jumps 36% in a week after the FDA clears Ekterly, the first oral on-demand therapy for hereditary angioedema.
